U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3 OMB APPROVAL
-----------------------------
OMB NUMBER: 3235-0104
Expires: December 31, 2001
Estimated average burden
hours per response ...... 0.5
-----------------------------
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
Beil Gary
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
21250 Hawthorne Boulevard
- --------------------------------------------------------------------------------
(Street)
Torrance CA 90503
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2000
- --------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
- --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Total Renal Care Holdings, Inc. (TRL)
- --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer:
(Check all applicable)
Director 10% Owner
----- ------
X Officer (give Other (Specify
----- title below) ------ below)
Vice President and Controller
- --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- --------------------------------------------------------------------------------
Table 1 -- Non-Derivative Securities Beneficially Owned
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect
Beneficially Owned Direct (D) or Beneficial Ownership
Indirect (I)
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5)
- -------------------------- --------------------------- ----------------- -----------------------
Common Stock 40,000 D
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
- -------------------------- --------------------------- ----------------- -----------------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
(Over)
SEC 1473 (8-92)
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security 2. Date Exer- 3. Title and Amount of Securities 4. Conversion 5. Ownership 6. Nature of
(Instr.4 cisable and Underlying Derivative Security or Exercise Form of Indirect
Expiration (Instr. 4) Price of Derivative Beneficial
Date Derivative Security: Ownership
(Month/Day/ Security Direct (D) (Instr. 5)
Year) or
--------------- --------------------------------- Indirect (I)
Date Expira- Amount (Instr. 5)
Exer- tion or
cisable Date Title Number
of
Shares
- ------------------------------- ------- ------- ------------------------ ------ ------------- --------------- -------------
Options (1) 11/29/09 Common Stock 60,000 $7.0625 D
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
(16b-3 plan; right to buy)
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
Options (2) 3/29/05 Common Stock 90,000 $2.6875 D
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
(16b-3 plan; right to buy)
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
- ------------------------------- ------- ------- ------------------------ -------- ------------- --------------- -------------
Explanation of Responses:
(1) The indicated option vests at 25% per year such that 15,000 shares vest on
each of the following dates: 11/29/2000; 11/29/2001; 11/29/2002; and
11/29/2003.
(2) The indicated option vests at 25% per year such that 22,500 shares vest on
each of the following dates: 3/29/2001; 3/29/2002; 3/29/2003; and
3/29/2004. The final installment was accelerated and became exercisable on
June 27, 2000, because the market price exceeded 1.864 times the exercise
price on ten out of twenty trading days.
**Intentional misstatements or omissions of fcats constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Gary Beil 9/25/00
_______________________________ ______________
**Signature of Reporting Person Date
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient,
See Instruction 6 for procedure.
